subscribeSubscribe
price-trendAsk Us
Sanofi to cut US price of its most-prescribed insulin by 78%

Sanofi to cut US price of its most-prescribed insulin by 78%
REUTERS
17 Mar 2023
Share Share
Sanofi`s Biologic APIDRA (Insulin Glulisine) Receives Approval in the U.S.

Sanofi`s Biologic APIDRA (Insulin Glulisine) Receives Approval in the U.S.
FDA
30 Nov 2022
Share Share
Sanofi talks up personalized diabetes care in patient-centric awareness push

Sanofi talks up personalized diabetes care in patient-centric awareness push
Beth Snyder Bulik FIERCE PHARMA
10 Jun 2019
Share Share
FDA Requires New Labeling on Insulin Pens to Ward off Spread of Infections

FDA Requires New Labeling on Insulin Pens to Ward off Spread of Infections
Varun Saxena FIERCE DRUG DELIVERY
03 Mar 2015
Share Share
It`s Put Up or Shut Up Time for Sanofi and Mannkind as Afrezza Hits the Market

It`s Put Up or Shut Up Time for Sanofi and Mannkind as Afrezza Hits the Market
Tracy Staton FIERCE PHARMA
03 Feb 2015
Share Share